News

Published on 2 Nov 2021 on Benzinga via Yahoo Finance

64 Biggest Movers From Yesterday


Article preview image

Gainers

ABVC BioPharma, Inc. (NASDAQ: ABVC) shares climbed 137.4% to close at $6.03 on Monday on abnormally-high volume. The stock is seeing increased interest by traders on social media. Also, the company filed a mixed shelf offering on Friday after the close.Mountain Crest Acquisition Corp. II (NASDAQ: BTTX) rose 84.3% to close at $17.14. The company completed merger with Mountain Crest Acquisition Corp II on Friday.Muscle Maker, Inc. (NASDAQ: GRIL) jumped 50.5% to close at $1.67 on Monday. Muscle Maker inked a Master Franchise Agreement for 40 units in the Kingdom of Saudi Arabia. The financial terms of the deal were not disclosed.ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) shares surged 49.5% to settle at $55.89 after reporting better-than-expected Q3 results. ANI Pharmaceuticals also announced the FDA approval of purified cortrophin gel for multiple indications including multiple sclerosis, rheumatoid arthritis and nephrotic syndrome.Vuzix Corporation (NASDAQ: VUZI) gained 32.3% to close at $14.14. AR-related stocks have seen momentum in recent sessions.FG Financial Group, Inc. (NASDAQ: FGF) rose 31.6% to settle at $5.08. FG Financial Group recently announced commencement of rights offering.ION Geophysical Corporation (NYSE: IO) shares surged 30.5% to close at $2.57. ION recently announced preliminary Q3 revenues of $44 to $45 million.Regencell Bioscience Holdings Limited (NASDAQ: RGC) rose 26.7% to close at $17.02.Comtech Telecommunications Corp. (NASDAQ: CMTL) climbed 26.1% to close at $27.20. Comtech confirmed the receipt of unsolicited proposal from Acacia Research.Cipher Mining Inc. (NASDAQ: CIFR) gained 25.3% to settle at $9.85.Kiromic BioPharma, Inc. (NASDAQ: KRBP) jumped 24.2% to settle at $2.77.Desktop Metal, Inc. (NYSE: DM) gained 23.8% to close at $8.66 after the company announced it tripled manufacturing capacity for Production System P-50.Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) surged 22.5% to settle at $12.73 following upbeat Q3 results.Armata Pharmaceuticals Inc. (NYSE: ARMP) gained 22.2% to close at $3.91 following Form 4 Filing from the company’s Director And 10% owner, Innoviva, showing purchase of 1.2 million shares.loanDepot, Inc. (NYSE: LDI) jumped 22% to close at $8.00 after the company reported better-than-expected Q3 financial results.Super League Gaming, Inc. (NASDAQ: SLGG) jumped 21.7% to settle at $3.82.Lightbridge Corporation (NASDAQ: LTBR) rose 21.7% to close at $11.65.Super League Gaming, Inc. (NASDAQ: SLGG) jumped 21.7% to settle at $3.82.Silvergate Capital Corporation (NYSE: SI) rose 21.5% to close at $190.34.Atreca, Inc. (NASDAQ: BCEL) gained 21.4% to close at $6.29.Virios Therapeutics, Inc. (NASDAQ: VIRI) rose 21.2% to settle at $5.66.Hyzon Motors Inc. (NASDAQ: HYZN) gained 20.9% to close at $6.30. Hyzon Motors unveiled its first zero-emission, fuel cell electric commercial coach in Brisbane last week.Danimer Scientific, Inc. (NYSE: DNMR) rose 20.4% to settle at $17.77.BioSig Technologies, Inc. (NASDAQ: BSGM) gained 20.4% to close at $3.25. BioSig Technologies said it exceeded its procedural target of 1,500 patient cases in 2021.The L.S. Starrett Company (NYSE: SCX) surged 20.1% to settle at $12.13.FuelCell Energy, Inc. (NASDAQ: FCEL) gained 19.3% to close at $9.53 as investors weighed President Joe Biden's speech at the 2021 United Nations Climate Change Conference, also known as COP26, in which he addressed climate change goals.Humacyte, Inc. (NASDAQ: HUMA) jumped 18.7% to settle at $10.80.Volta Inc. (NYSE: VLTA) climbed 18.2% to close at $9.62 after jumping 10% on Friday.Ocugen, Inc. (NASDAQ: OCGN) climbed 18.1% to settle at $13.98 after climbing 13% on Friday. Traders circulated earlier release from Australian government mentioning recognition of Bharat Biotech's COVAXIN. Ocugen is a partner on COVAXIN.Golden Star Resources Ltd. (NYSE: GSS) gained 16.8% to settle at $3.68. Chifeng Jilong Gold announced plans to acquire Golden Star in all-cash offer valued at $470 million.Zosano Pharma Corporation (NASDAQ: ZSAN) shares gained 16.1% to close at $0.7020. The company, on Friday, announced it received full data tables from its pharmacokinetic study and submitted a briefing package to the FDA.Novavax, Inc. (NASDAQ: NVAX) rose 15.8% to close at $172.45 after the company announced the completion of its rolling submission to Health Canada for authorization of its COVID-19 vaccine candidate.Ciner Resources LP (NYSE: CINR) rose 14.5% to close at $18.60.ON Semiconductor Corporation (NASDAQ: ON) climbed 14.4% to close at $54.99 after the company reported better-than-expected Q3 financial results.Xilio Therapeutics, Inc. (NASDAQ: XLO) gained 13.3% to settle at $19.02.Archer Aviation Inc. (NYSE: ACHR) rose 12.5% to close at $6.41. Archer Aviation is expected to release its Q3 financial results on Thursday, November 11, 2021.3D Systems Corporation (NYSE: DDD) gained 12.3% to settle at $31.61.GLOBALFOUNDRIES Inc. (NASDAQ: GFS) climbed 10.5% to close at $53.87 after gaining 5% on Friday. The company, last week, priced its IPO at $47 per share.JAKKS Pacific, Inc. (NASDAQ: JAKK) gained 9.6% to close at $11.50. The company, last week, posted mixed quarterly results.Valneva SE (NASDAQ: VALN) rose 9.4% to close at $48.82 after the company reported full exercise of underwriters’ option to purchase additional ADSs, bringing gross proceeds of global offering to around $102.0 million.Harley-Davidson, Inc. (NYSE: HOG) rose 9.1% to close at $39.80. Harley-Davidson, last week, reported better-than-expected Q3 EPS and motorcycle sales results.E-Home Household Service Holdings Limited (NASDAQ: EJH) shares gained 8.5% to close at $2.93.Ophazyme A/S (NASDAQ: ORPH) shares rose 7.5% to close at $4.18 after the company issued a regulatory update following Type A meeting with the FDA on arimoclomol in Niemann-Pick disease type C.DBV Technologies S.A. (NASDAQ: DBVT) gained 7.3% to close at $3.25. DBV Technologies will highlight new long-term data from REALISE trial at American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting.Evelo Biosciences, Inc. (NASDAQ: EVLO) rose 7% to close at $9.47. Chardan Capital upgraded Evelo Biosciences from Neutral to Buy and maintained a $12 price target.First Wave BioPharma, Inc. (NASDAQ: FWBI) gained 6.3% to close at $2.72.

NASDAQ.OCGN price evolution
NYSE.SCX price evolution
NASDAQ.SLGG price evolution
NASDAQ.BTBT price evolution
NYSE.DDD price evolution
NASDAQ.KRBP price evolution
NASDAQ.VIRI price evolution
NASDAQ.KTTA price evolution
NASDAQ.BCEL price evolution
NASDAQ.MARK price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Ocugen (OCGN) to Report Q1 Earnings: What's in the Cards?

Ocugen, Inc. OCGN is likely to provide updates on its pipeline developments when it reports first...

Zacks via Yahoo Finance 26 Apr 2024

Stockholder Alert: Robbins LLP Informs Investors of the Class Action Filed Against Ocugen, Inc....

Stockholder Alert: Robbins LLP Informs Investors of the Class Action Filed Against Ocugen, Inc....

Investing.com 11 Apr 2024

Ocugen stock gains says EU backs U.S. trial for gene therapy

Ocugen (OCGN) stock gains as company wins EU nod for a U.S. trial for its gene therapy candidate,...

Seeking Alpha 10 Apr 2024

Ocugen's gene therapy OCU400 advances in Europe

Ocugen, Inc. ( NASDAQ : NASDAQ: OCGN ), a biotechnology company specializing in gene and cell the...

Investing.com 10 Apr 2024

Ocugen (OCGN) Up as DSMB Allows Cohort 2 Dosing in GA Study

Ocugen, Inc. OCGN announced that the Data and Safety Monitoring Board (“DSMB”) for the early to m...

Zacks via Yahoo Finance 8 Apr 2024

Why Ocugen Stock Is Climbing Today - Ocugen (NASDAQ:OCGN)

Ocugen, Inc. OCGN shares are trading higher Friday after the company announced it has received ap...

Benzinga 5 Apr 2024

Ocugen advances to mid-dose trial for eye disease therapy

Ocugen, Inc. (NASDAQ: NASDAQ: OCGN ), a biotechnology firm engaged in the development of gene...

Investing.com 5 Apr 2024

Ocugen stock gains as study for eye disease therapy advances

Ocugen (OCGN) stock gains as its Phase 1/2 trial for gene therapy candidate OCU410 for geographic...

Seeking Alpha 5 Apr 2024

Signet Jewelers, Dave & Buster's Entertainment, Blue Owl Capital And Other Big Stocks Moving Higher...

U.S. stocks were higher, with the Dow Jones gaining over 50 points on Wednesday. Shares of Signet...

Benzinga 3 Apr 2024

Why Ocugen Shares Are Popping Off - Ocugen (NASDAQ:OCGN)

Ocugen Inc OCGN shares are trading higher by 14% to $1.58 during Wednesday’s session. The company...

Benzinga 3 Apr 2024